Eutilex Co.,Ltd.
Eutilex - Model EU101 -Fully Humanized Anti-Human 4-1BB Monoclonal Antibody
FromEutilex Co.,Ltd.
Fully humanized anti-human 4-1BB monoclonal antibody. Agonistic effect of EU101 promotes cytotoxic T lymphocyte response and it leads to eradication of cancer.
Most popular related searches
monoclonal antibody
human monoclonal antibody
in vivo efficacy
immune checkpoints
therapeutic antibody
immune checkpoint
tumor targeting
tumor tissue
T-cell
in vivo human
Indication
Solid tumor
Target /Drug class
Anti-human 4-1BB mAb
Development Stage
Phase I/II study
- Anti-human 4-1BB monoclonal therapeutic antibody
- Better efficacy for tumor clearance than competitors in vivo
- Accelerates infiltration of lymphocyte into tumor tissue
- Promising platform technology for combination therapy with immune checkpoint inhibitors
